MSB 1.49% $1.02 mesoblast limited

Alzheimer drug approved, page-24

  1. 5,708 Posts.
    lightbulb Created with Sketch. 2051
    Really good article about this really crazy situation in buzzfeed


    https://www.buzzfeednews.com/article/stephaniemlee/alzheimers-aducanumab-biogen-fda-approval?origin=web-hf

    A Highly Controversial Alzheimer’s Treatment Won FDA Approval. Scientists Say We Don’t Know If It Actually Works.

    In one sense, aducanumab is a historic drug — but many scientists say its approval is a triumph of business interests over public health.

    Last updated on June 7, 2021, at 7:45 p.m. ET

    Posted on June 7, 2021, at 1:20 p.m. ET






 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.02
Change
0.015(1.49%)
Mkt cap ! $1.164B
Open High Low Value Volume
$1.00 $1.04 94.0¢ $11.76M 11.90M

Buyers (Bids)

No. Vol. Price($)
6 206912 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 37637 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.